NATCO PHARMA USA Trademark

Trademark Overview


On Thursday, April 25, 2024, a trademark application was filed for NATCO PHARMA USA with the United States Patent and Trademark Office. The USPTO has given the NATCO PHARMA USA trademark a serial number of 98518715. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 25, 2024. This trademark is owned by Natco Pharma USA LLC. The NATCO PHARMA USA trademark is filed in the Pharmaceutical Products category with the following description:

allergy medications; anticonvulsants; anti-constipation medicines; anti-fungals; antihistamines; cough suppressants; cough-treatment medicines; expectorants; irritable-bowel-syndrome treatments; laxatives; medicated mouthwash; medicated mouthwash for the treatment of gingivitis; medicines for alleviating constipation; milk of magnesia; nausea treatments; stool softeners; ulcer medicines; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of sleep apnea, narcolepsy, and shift-work sleep disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of nausea and vomiting from cancer-related chemotherapy, radiation, and surgery; pharmaceutical preparations for the treatment of anxiety disorders; pharmaceutical preparations for the treatment of stomach pain, bloating, and straining; pharmaceutical preparations for the treatment of seizur...
natco pharma usa

General Information


Serial Number98518715
Word MarkNATCO PHARMA USA
Filing DateThursday, April 25, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesallergy medications; anticonvulsants; anti-constipation medicines; anti-fungals; antihistamines; cough suppressants; cough-treatment medicines; expectorants; irritable-bowel-syndrome treatments; laxatives; medicated mouthwash; medicated mouthwash for the treatment of gingivitis; medicines for alleviating constipation; milk of magnesia; nausea treatments; stool softeners; ulcer medicines; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of sleep apnea, narcolepsy, and shift-work sleep disorders; pharmaceutical products for the treatment of cancer; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for the treatment of nausea and vomiting from cancer-related chemotherapy, radiation, and surgery; pharmaceutical preparations for the treatment of anxiety disorders; pharmaceutical preparations for the treatment of stomach pain, bloating, and straining; pharmaceutical preparations for the treatment of seizures related to epilepsy; pharmaceutical preparations for the treatment of chest congestion; pharmaceutical preparations for the treatment of angina pectoris and chronic heart failure, namely, nitroglycerin

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2024
Primary Code005
First Use Anywhere DateFriday, March 8, 2024
First Use In Commerce DateFriday, March 8, 2024

Trademark Owner History


Party NameNatco Pharma USA LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, US 07054

Trademark Events


Event DateEvent Description
Thursday, April 25, 2024NEW APPLICATION ENTERED
Thursday, April 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED